SCHEMBL5861890

SCHEMBL5861890

Cc1ccc(S(=O)(=O)c2ccc(C)nc2Nc2c(C)cc(C)cc2C)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5861157 0.91 — —
SCHEMBL5862240 0.91 — —
SCHEMBL5861076 0.91 — —
SCHEMBL5862456 0.90 — —
SCHEMBL5861014 0.89 — —
SCHEMBL5862247 0.89 — —
SCHEMBL5862275 0.89 RAPGEF4 (0.56) —
SCHEMBL5861163 0.89 — —
SCHEMBL5862405 0.88 — —
SCHEMBL5861166 0.87 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7030145-B2 Pyridinyl derivatives for the treatment of depression BRISTOL-MYERS SQUIBB COMPANY (US) 2006-04-18 — — US claimed
US-20040209917-A1 Pyridinyl derivatives for the treatment of depression HARTZ RICHARD A (US) 2004-10-21 — — US claimed
US-7030145-B2 Pyridinyl derivatives for the treatment of depression BRISTOL-MYERS SQUIBB COMPANY (US) 2006-04-18 — — US disclosed
US-20040209917-A1 Pyridinyl derivatives for the treatment of depression HARTZ RICHARD A (US) 2004-10-21 — — US disclosed
Send feedback